NeuroRx CEO, Jonathan Javitt, and Head of Operations/CCO, Robert Besthof, discuss the logistics and trial progress of their COVID-19 drug. Operating clinical trials of a COVID-19 drug comes with many challenges, not the least of the pandemic’s limitations. NeuroRx CEO Jonathan Javitt, MD, MPH, and Head of Operations/CCO Robert Besthof discuss the logistics and clinical […]

Athira Pharma has been awarded a $15 million grant from the National Institute on Aging to support its phase 2 randomized, placebo-controlled ACT-AD trial (NCT04491006) investigating ATH-1017 for mild-to-moderate Alzheimer disease (AD).1  ATH-1017, a small-molecule therapeutic, promotes the activity of Hepatocyte Growth Factor (HGF) and its receptor, MET, which are expressed in the central nervous […]

Aurobindo Pharma has signed an agreement to develop and commercialise Covaxx’s Covid-19 vaccine (UB-612) for India and UNICEF. UB-612 is a synthetic peptide-based vaccine candidate and currently in the Ph-I and expected to enter Ph-II/III in early 1QCY21. Aurobindo Pharma currently has the capacity of manufacturing 220m dosages annually and augmenting the capacity to manufacture […]